Less is more: Exploring neoadjuvant immunotherapy as a de-escalation strategy in head and neck squamous cell carcinoma treatment
LM Cao, NN Zhong, Y Chen, ZZ Li, GR Wang, Y **ao… - Cancer Letters, 2024 - Elsevier
Head and neck squamous cell carcinoma (HNSCC) constitutes a significant global cancer
burden, given its high prevalence and associated mortality. Despite substantial progress in …
burden, given its high prevalence and associated mortality. Despite substantial progress in …
[HTML][HTML] Oral cancer: recent breakthroughs in pathology and therapeutic approaches
S Ramachandran - Oral Oncology Reports, 2024 - Elsevier
Oral cancer, primarily oral squamous cell carcinoma (OSCC), continues to be a major global
health challenge. Despite improvements in early detection and treatment, the prognosis for …
health challenge. Despite improvements in early detection and treatment, the prognosis for …
Suicide among patients with oral cancer: a population-based study
GR Wang, HQ Wang, NN Zhong, LM Cao, ZZ Li… - Cancer …, 2024 - Elsevier
Background Patients with oral cancer usually experience disfigurement and dysfunction
which are shared risk factors of suicide. The aim of the study was to comprehensively assess …
which are shared risk factors of suicide. The aim of the study was to comprehensively assess …
Immediate postoperative minimal residual disease detection with MAESTRO predicts recurrence and survival in head and neck cancer patients treated with surgery
Purpose: While circulating tumor DNA (ctDNA) is a promising biomarker for minimal residual
disease (MRD) detection in head and neck squamous cell carcinoma (HNSCC), more …
disease (MRD) detection in head and neck squamous cell carcinoma (HNSCC), more …